Background illustration for clinical trials search

Paid Clinical Trials Indiana

Discover 1,106 paid clinical trials in Indiana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

An Extension Study to Evaluate the Efficacy and Safety of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS

for
RLS
Location: Winter Park FL, Columbia SC, Indianapolis IN,
Sponsor: XenoPort, Inc.

Sex: All

Age: 13 - 17

Code: NCT02633683

Recruiting

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: New Haven CT, Brooklyn NY, New York NY, Montreal,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06350097

Phase3, Recruiting

Hemlibra in Mild Hemophilia A

for
Factor VIII Deficiency, Congenital
Location: Indianapolis IN
Sponsor: Indiana Hemophilia &Thrombosis Center, Inc.

Sex: Male

Age: 5 - 45

Code: NCT04567511

Recruiting

A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)

for
Von Willebrand Disease (VWD)
Location: New York NY, New Brunswick NJ, Charleston SC,
Sponsor: Takeda

Sex: All

Age: 0 - 17

Code: NCT05582993

Phase3, Recruiting

Abatacept in Immune Checkpoint Inhibitor Myocarditis

for
Myocarditis Acute, Cancer
Location: Portland ME, Boston MA, New York NY, New Brunswick NJ,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT05335928

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Location: Boston MA, Stoneham MA, Westerly RI, Waterford CT,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT04566328

Phase3, Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

for
Hematologic Disorder, Bleeding Disorder,
Location: Scarborough ME, Providence RI, Hartford CT,
Sponsor: American Thrombosis and Hemostasis Network

Sex: All

Age: 0+

Code: NCT04398628

Recruiting

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

for
Cardiotoxicity, HER2/Neu Positive,
Location: Winchester MA, Burlington MA, White Plains NY, Nyack NY,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT03418961

Phase3, Recruiting

Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)

for
PSC
Location: Boston MA, New Haven CT, Montreal, Richmond VA,
Sponsor: PSC Partners Seeking a Cure

Sex: All

Age: 18 - 70+

Code: NCT06297993

Recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Halifax, Portland ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554393

Phase2, Recruiting

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for
Non-Small Cell Lung Cancer
Location: St. John's, Rimouski, Boston MA, Levis, Stony Brook NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06357533

Phase3, Recruiting

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

for
Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer,
Location: Boston MA, New York NY, Fairfax VA, Pittsburgh PA,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06128551

Phase1, Phase2, Recruiting

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

for
Tardive Dyskinesia
Location: Durham NC, Miami Beach FL, North Miami FL,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT03062033

Recruiting

Persona Revision Knee System Outcomes

for
Arthroplasty Complications, Infection, Knee Disease,
Location: Chester NJ, Cleveland OH, Rochester MI, Southfield MI,
Sponsor: Zimmer Biomet

Sex: All

Age: 18+

Code: NCT04821154

Recruiting

Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2

for
Post Operative Surgical Site Infection
Location: Boston MA, Providence RI, Lebanon NH, Jamaica NY,
Sponsor: Major Extremity Trauma Research Consortium

Sex: All

Age: 18 - 64

Code: NCT04678154

Phase3, Recruiting

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

for
Multiple Myeloma
Location: Boston MA, New York NY, Chapel Hill NC,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05137054

Phase1, Recruiting

Follow-up Visit of High Risk Infants

for
Infant, Newborn, Infant, Low Birth Weight,
Location: Philadelphia PA, Durham NC, Cleveland OH, Detroit MI,
Sponsor: NICHD Neonatal Research Network

Sex: All

Age: 1 - 2

Code: NCT00009633

Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for
Triple Negative Breast Cancer
Location: Scarborough ME, South Weymouth MA, Boston MA,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase3, Recruiting

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

for
Tricuspid Regurgitation, Tricuspid Valve Insufficiency,
Location: Boston MA, Lebanon NH, Roslyn NY, New York NY,
Sponsor: Edwards Lifesciences

Sex: All

Age: 18+

Code: NCT04097145

Recruiting

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Moncton, Sherbrooke, Albany NY, Greenfield Park,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05947851

Phase3, Recruiting

Popular cities in Indiana

IndianapolisSouth BendFort WayneEvansville